Optimizing Surgical Outcomes through Albumin-guided Strategies

Sir, Body fluid replacement is a critical step in patient management in intensive care units (ICUs) and during major abdominal surgeries for maintenance of hemodynamic stability, to support organ perfusion, and in the prevention of complications arising from hypovolemia. In ICUs, ongoing losses from sepsis, trauma, drains, or GI disturbances like vomiting and diarrhea necessitate continuous assessment of volume status and tailored fluid therapy to maintain microcirculatory flow. On the other hand, in abdominal surgeries, major fluid shifts occur due to surgical stress, bowel handling, third-space loss, and evaporation from exposed viscera, making timely and accurate fluid replacement very crucial.1 Although crystalloids are the first-line agents in fluid therapy, colloids are used when rapid and sustained plasma volume expansion is mandatory. Human albumin, a natural colloid, is preferred due to its superior volume-expanding properties, lower risk of coagulopathy, and beneficial effects on endothelial function.2 Albumin is now the recommended colloid for intravenous therapy due to worries about the negative effects of starch-based colloids in critically ill patients and the lack of a clear perioperative advantage.3,4 While postoperative albumin (P-Alb) infusions have not consistently demonstrated therapeutic benefit, albumin given during surgery may assist maintain colloid osmotic pressure and minimize intestinal edema.3 Low P-Alb values below 25 g/L on the 1st postoperative day predict serious problems, such as pancreatic fistula following pancreaticoduodenectomy, while the clinical relevance of this condition is still relatively unknown. Since C-reactive protein levels usually peak between the first and third postoperative days following large abdominal procedures, the timing of capillary leakage following surgery is poorly documented but may reflect the postoperative inflammatory response. The marked decline in Plasma Albumin appears partly attributable to extravasation, as approximately 19 ± 12 g of albumin could not be accounted for when comparing intravascular albumin loss with albumin administered and measured. The common causes of hypoalbuminemia are decreased hepatic synthesis, increased loss, or altered distribution of albumin within the body. Conditions such as chronic liver disease, malnutrition, inflammation, nephrotic syndrome, protein-losing enteropathy, and major burns are the frequent causes of reduced circulating albumin levels. Hypoalbuminemia impairs the colloid osmotic pressure, leading to edema, ascites, and pleural effusion. It also affects the transport and binding of drugs and hormones. In the perioperative setting, hypoalbuminemia leads to impaired wound healing, increased susceptibility to infections, and poor surgical outcomes, making its identification and correction essential.5,6 Plasma C-reactive protein levels on postoperative day 2 ranged widely between 24 and 234 mg/L in patients undergoing pancreaticoduodenectomy, indicating substantial variability in the inflammatory response. This variability may explain why capillary leakage in our cohort did not match the increased leakage observed after thoracic surgery¹. Plasma volume estimates derived using anthropometric equations6 and corrected hematocrit values closely matched measured values, supporting the reliability of our calculations. The major focus in the prevention of albumin loss lies in treating the underlying condition causing inflammation, capillary leakage, or reduced synthesis while improving overall nutrition and metabolic status. Various measures, such as optimization of protein intake, early nutritional therapy, and control of sepsis or systemic inflammation, will play a role in preserving hepatic albumin production. Further albumin depletion can be avoided by avoiding nephrotoxic shocks and excessive fluid resuscitation, as well as by replacing lost renal or gastrointestinal protein as soon as possible. Serum albumin is a useful and affordable biomarker for perioperative risk assessment, according to complications in a variety of surgical and medical scenarios. Albumin testing is a useful way to assess a patient’s condition before surgery because it is easy and frequently carried out. In line with the findings of Gibbs et al.,4 our analysis found that patients with preoperative hypoalbuminemia had greater rates of unfavorable outcomes within 30 days across eight surgical specialties. Even higher hazards, such as higher postoperative mortality, were present in patients with disseminated cancer. Prior research has demonstrated that in critically ill and surgical patients, early enteral feeding, the use of anti-inflammatory techniques, and goal-directed hydration management will greatly reduce hypoalbuminemia.5,6 In addition, studies show that maintaining normal albumin levels is linked to better overall clinical outcomes, better wound healing, and fewer postoperative complications.4 Preoperative serum albumin’s function as an independent predictor of short-term surgical risk is supported by the evidence. The increased effect seen in individuals with extensive cancer demonstrates how inflammation, dietary state, surgical recovery, and systemic disease burden interact. Overall, our findings support the use of albumin measurement in standard preoperative risk stratification models since it accurately reflects metabolic and inflammatory states that influence postoperative morbidity and mortality. Emphasizes albumin’s critical involvement in immune function, collagen formation, and tissue repair processes required for postoperative recovery. Effective control and optimization of albumin levels in certain patient categories may help to reduce risks and enhance surgical results. Financial support and sponsorship Nil. Conflicts of interest There are no conflicts of interest.